Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
SEC Accession No. 0001171520-22-000148
Filing Date
2022-02-23
Accepted
2022-02-22 19:10:49
Documents
1

Document Format Files

Seq Description Document Type Size
1 eps10101.htm DFAN14A 20764
  Complete submission text file 0001171520-22-000148.txt   22088
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Subject) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
Type: DFAN14A | Act: 34 | File No.: 000-51173 | Film No.: 22660165
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2200 FLETCHER AVENUE SUITE 501 FORT LEE NJ 07024
Business Address
SINGER JULIAN D. (Filed by) CIK: 0001628706 (see all company filings)

Type: DFAN14A